JP2022533227A5 - - Google Patents
Info
- Publication number
- JP2022533227A5 JP2022533227A5 JP2021569059A JP2021569059A JP2022533227A5 JP 2022533227 A5 JP2022533227 A5 JP 2022533227A5 JP 2021569059 A JP2021569059 A JP 2021569059A JP 2021569059 A JP2021569059 A JP 2021569059A JP 2022533227 A5 JP2022533227 A5 JP 2022533227A5
- Authority
- JP
- Japan
- Prior art keywords
- angles
- ray powder
- powder diffraction
- diffraction peaks
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851344P | 2019-05-22 | 2019-05-22 | |
| US62/851,344 | 2019-05-22 | ||
| PCT/US2020/033992 WO2020237047A1 (en) | 2019-05-22 | 2020-05-21 | Crystalline salt forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533227A JP2022533227A (ja) | 2022-07-21 |
| JP2022533227A5 true JP2022533227A5 (https=) | 2023-05-29 |
Family
ID=71016713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569059A Ceased JP2022533227A (ja) | 2019-05-22 | 2020-05-21 | Ｎ－（４－（４－（シクロプロピルメチル）ピペラジン－１－カルボニル）フェニル）キノリン－８－スルホンアミドの結晶性塩形態 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230192618A1 (https=) |
| EP (1) | EP3972957A1 (https=) |
| JP (1) | JP2022533227A (https=) |
| CN (2) | CN114026071B (https=) |
| AU (1) | AU2020280045A1 (https=) |
| CA (1) | CA3145138A1 (https=) |
| IL (1) | IL288158A (https=) |
| MX (2) | MX2021014228A (https=) |
| WO (1) | WO2020237047A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL312679A (en) | 2021-11-16 | 2024-07-01 | Agios Pharmaceuticals Inc | Compounds for the treatment of anemia associated with MDS and other conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7998505B2 (en) * | 2006-10-27 | 2011-08-16 | Fmc Corporation | Dry granulation binders, products, and use thereof |
| TWI598337B (zh) * | 2009-06-29 | 2017-09-11 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| TWI730959B (zh) * | 2015-05-19 | 2021-06-21 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺 |
| CA2989111C (en) | 2015-06-11 | 2023-10-03 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| KR102777452B1 (ko) * | 2017-11-22 | 2025-03-10 | 아지오스 파마슈티컬스 아이엔씨. | N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의결정 형태 |
-
2020
- 2020-05-21 WO PCT/US2020/033992 patent/WO2020237047A1/en not_active Ceased
- 2020-05-21 JP JP2021569059A patent/JP2022533227A/ja not_active Ceased
- 2020-05-21 AU AU2020280045A patent/AU2020280045A1/en not_active Abandoned
- 2020-05-21 MX MX2021014228A patent/MX2021014228A/es unknown
- 2020-05-21 CN CN202080045139.1A patent/CN114026071B/zh active Active
- 2020-05-21 US US17/612,554 patent/US20230192618A1/en not_active Abandoned
- 2020-05-21 EP EP20731357.8A patent/EP3972957A1/en not_active Withdrawn
- 2020-05-21 CN CN202410205860.2A patent/CN118206485A/zh active Pending
- 2020-05-21 CA CA3145138A patent/CA3145138A1/en active Pending
-
2021
- 2021-11-16 IL IL288158A patent/IL288158A/en unknown
- 2021-11-19 MX MX2024009648A patent/MX2024009648A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504338A5 (https=) | ||
| JP7275130B2 (ja) | Ｎ－（４－（４－（シクロプロピルメチル）ピペラジン－１－カルボニル）フェニル）キノリン－８－スルホンアミドの結晶性形態 | |
| KR102425226B1 (ko) | Jak 저해제를 포함하는 제약 조성물 | |
| TWI846166B (zh) | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途 | |
| TW200800221A (en) | δD-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it | |
| JP7667270B2 (ja) | １－（３－シアノ－１－イソプロピル－インドール－５－イル）ピラゾール－４－カルボン酸の結晶性粒子の製造方法およびそれを含む薬学的組成物 | |
| JP2022533227A5 (https=) | ||
| US11345706B2 (en) | Crystalline forms of Acalabrutinib | |
| JP2023536667A5 (https=) | ||
| US20170226119A1 (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof | |
| CN115427112B (zh) | 2-[(4s)-8-氟-2-[4-(3-甲氧基苯基)哌嗪-1-基]-3-[2-甲氧基-5-(三氟甲基)苯基]-4h-喹唑啉-4-基]乙酸钾盐 | |
| KR20130095735A (ko) | 테노포비어 디소프록실 푸마레이트의 결정 | |
| JP2022007461A (ja) | トルバプタン含有口腔内崩壊錠 | |
| NZ805778A (en) | Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1- carbonyl)phenyl)quinoline-8-sulfonamide | |
| WO2018150335A1 (en) | Novel cocrystal of lesinurad and process for the preparation thereof | |
| US20200002343A1 (en) | Crystalline Form of Ribociclib Succinate | |
| EA049155B1 (ru) | Калиевая соль 2-[(4s)-8-фтор-2-[4-(3-метоксифенил)пиперазин-1-ил]-3-[2-метокси-5-(трифторметил)фенил]-4н-хиназолин-4-ил]уксусной кислоты | |
| JP2013103924A (ja) | 結晶性アトルバスタチンカルシウム含有錠剤の製造方法 | |
| HK1213549B (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof |